Peer Review History
| Original SubmissionMay 19, 2025 |
|---|
|
Dear Dr. Kaida, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Sep 20 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Yosuke Yamada Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 3. Thank you for stating the following in the Acknowledgments Section of your manuscript: We are grateful to Kiyoshi Yoshinaka, Naotaka Nitta, Mototada Shichiri, Hiroshi Endo, Sayaka Higo-Yamamoto, Chisa Emura for critical discussions. We thank CPCC Co., Ltd. (Tokyo, Japan) for conducting the clinical trial. We thank Suntory Beverage & Food Limited for financial support and Hiroyuki Kato, Susumu Takemoto, Yasuhiro Tanaka for helpful comments regarding the experimental protocol and this draft of the manuscript. We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: The study was funded by Suntory Beverage & Food Limited (Tokyo, Japan). Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 4. We note that you have indicated that there are restrictions to data sharing for this study. For studies involving human research participant data or other sensitive data, we encourage authors to share de-identified or anonymized data. However, when data cannot be publicly shared for ethical reasons, we allow authors to make their data sets available upon request. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Before we proceed with your manuscript, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible. Please update your Data Availability statement in the submission form accordingly. 5. Please ensure that you refer to Figure 4 in your text as, if accepted, production will need this reference to link the reader to the figure. 6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 7. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: No ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: No Reviewer #2: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: No Reviewer #2: Yes ********** Reviewer #1: This manuscript investigates the effects of plain water intake before bedtime on sleep parameters and depressive mood in middle-aged Japanese men. The study consists of two parts: a large-scale online survey and a laboratory-based experimental intervention. The research question is highly relevant and of significant public health interest, particularly given the potential for simple behavioral interventions to influence mental health and sleep quality. However, there are several points where the manuscript could be improved to enhance clarity, scientific rigor, and overall readability. 1.There is a contradiction regarding REM sleep latency. The Abstract states that REM sleep latency was prolonged following water intake, whereas the General Discussion states that “plain water intake reduced REM sleep latency.” This is a critical inconsistency and should be corrected throughout the manuscript for clarity and accuracy. 2. The manuscript reports numerous t-tests without any mention of correction for multiple comparisons. Given the number of outcomes tested (e.g., sleep parameters, CES-D, PVT), the potential for Type I error is significant. Please discuss whether adjustments (e.g., Bonferroni correction, FDR) were considered. Although Cohen’s d values are consistently reported, it would be helpful to interpret the effect sizes in context (e.g., small, medium, large). 3. While the negative correlation between water intake and CES-D scores in Study 1 is statistically significant (r = -0.18), the effect size is small. The authors should clarify the practical significance of this association and temper conclusions accordingly. 4. Study 2 participants reported CES-D scores averaging around 8, which is lower than the typical mean (~12) in the Japanese population. This suggests the sample was generally mentally healthy, which could limit the generalizability of findings. This limitation should be emphasized more explicitly in the Discussion. 5. Although the manuscript notes that nocturia frequency increased with pre-bedtime water intake, the clinical risks of nocturia, particularly among older adults (e.g., risk of falls and fractures), should be discussed in greater detail to provide context for the practical implications of this side effect. 6. Several sentences could be revised for improved academic English. 7. Some figure legends, such as Figure 5, are rather brief. Adding brief descriptions of the main findings shown in the figures would improve reader comprehension. Some abbreviations (e.g., ECW, TBW) should be defined in figure legends where first used. Overall, this is a valuable and well-designed study addressing an underexplored topic of significant public health interest. The combination of observational and experimental approaches strengthens the validity of the findings. The required revisions relate mainly to clarifying inconsistencies, improving statistical reporting, and enhancing the clarity of language and interpretation. With these changes, the manuscript would be a strong candidate for publication in PLOS ONE. Reviewer #2: General Comments If this manuscript is intended to report two studies within a single paper, the current structure—where each study has separate background and discussion sections—makes the paper difficult to follow and disrupts its logical flow. I strongly recommend either: 1.Submitting the studies as two separate manuscripts, or 2.Presenting Study 1 and Study 2 only in the Methods and Results sections, while maintaining unified Introduction, Discussion, and Conclusion sections. Additionally, the manuscript must conform to the structural format commonly accepted by the journal, namely: Introduction, Materials and Methods, Results, Discussion, and Conclusion. The current structure impairs readability and comprehension. Major Comments Page 14, Line 1 – Table 1 •The reported TST appears short (approximately 300 minutes). Was this due to the unfamiliar hotel environment? Although the Morningness-Eveningness Questionnaire indicated that participants were, on average, of intermediate chronotype, individual variation might have affected sleep duration under experimental conditions. •Both trials show high WASO; could this also be due to discomfort in the hotel setting or increased nocturnal urination? •Interestingly, despite the increase in nocturia, WASO did not increase accordingly. This may suggest a novel observation that warrants further discussion. •Was wake-up time standardized? Did participants truly secure 7.5 hours of sleep as suggested in the figure? Page 11, Line 4 – “average water loss during sleep (400–700 mL)” •It is unclear how this estimate justifies the choice of 280 mL of plain water before bedtime. Please clarify the rationale behind selecting this amount. Page 17, Line 19 – General Discussion •The discussion focuses on concerns about dehydration, but it is unclear—both from the methods and the background—why plain water was selected as the rehydration fluid. •If dehydration mitigation was a concern, previous studies have shown that beverages containing electrolytes and/or carbohydrates are more effective for hydration maintenance or recovery. •The current data also suggest that plain water may lead to rapid excretion through urine, potentially increasing nocturnal urination and mid-sleep awakenings. •However, WASO did not increase despite increased nocturia—please explain this apparent discrepancy. Page 19, Line 2 – REM Latency and REM Sleep •REM latency increased and REM duration decreased. Would such changes positively influence the clearance of neural waste products or psychological recovery during sleep? •Line 57 seems to suggest the opposite. If I have misunderstood, I apologize—but clarification is needed as this appears contradictory. Page 17, Line 26 – Statement: “We determined that plain water intake reduced the amount of REM sleep and increased REM sleep latency.” •This conclusion seems inconsistent with the overall claims of the study. Please ensure alignment between the data and key conclusions. Figure 4 – ECW/TBW Differences •The difference in ECW/TBW ratios raises concern about experimental control. Although the study appears to have been carefully conducted, could the timing or content of pre-sleep meals or trial food have influenced these values? •Please include discussion of potential confounding factors, including any interaction effects. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Dear Dr. Kaida, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jan 25 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Yosuke Yamada Academic Editor PLOS One Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: The authors have addressed all prior reviewer and editorial concerns thoroughly. Major issues such as (1) inconsistency in REM sleep latency, (2) statistical transparency, (3) data availability, and (4) funding statement alignment have been satisfactorily resolved. The revised version demonstrates careful editing and a clear methodological rationale. The manuscript now meets the criteria for publication in PLOS ONE. The scientific quality is sound, and the conclusions are appropriately cautious and supported by the data. Minor textual polishing may still be needed (e.g., standardizing expressions of “trend” to “marginally significant”), but these do not affect the overall integrity of the work. This revised version reflects substantial improvement. The writing is clear, the structure coherent, and the key revisions have resolved the previous methodological and interpretive concerns. I appreciate the authors’ careful attention to detail and transparent responses to every comment. * The contradiction regarding REM sleep latency and duration has been corrected and now aligns with the reported findings. * The Discussion appropriately acknowledges confounding factors (hydration status, ECW/TBW differences, seasonal and environmental effects). * Statistical methods and figure legends have been clarified; multiple comparison procedures are now explicitly described. * Funding, ethics, and data availability statements fully comply with PLOS ONE requirements. Minor Points for Further Improvement 1. Statistical phrasing: Replace “trend” with “marginally significant (p = …)” for clarity and to conform to journal style. 2. Conclusion tone: The last paragraph (“advantages and disadvantages”) could end with a more forward-looking statement, such as: Further studies including participants with depressive symptoms are warranted to generalize the findings. 3. Language consistency:Consider minor stylistic edits (e.g.,ameliorated depressive mood → “improved morning mood”) for smoother readability. 4. Data statement: Confirm that Supporting Information files correspond exactly to the datasets referenced in the Results. Overall, this version is scientifically sound and clearly presented. I commend the authors for their comprehensive and thoughtful revision. Reviewer #2: I have no further major comments. However, I noticed that the number of subjects in the manuscript is slightly different from the UMIN registration (UMIN000054134, Registration Date: 05/01/2024). May be 62. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 2 |
|
Effects of plain water intake before bedtime on sleep and depressive mood among middle-aged Japanese men. PONE-D-25-22869R2 Dear Dr. Kaida, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Yosuke Yamada Academic Editor PLOS One Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-25-22869R2 PLOS One Dear Dr. Kaida, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Yosuke Yamada Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .